A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) ClinicalTrials.gov Accessed on 20 Dec 2011 from http://clinicaltrials.gov/ct2/show/NCT01037907. CommentRecommendBookmarkWatch